Huang W.-C.Tsai C.-C.Wei M.-C.KUAN-TING KUO2020-03-072020-03-0720130002-9378https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880908725&doi=10.1016%2fj.ajog.2013.05.044&partnerID=40&md5=44991c892953fe144647fa863e1c8e45https://scholars.lib.ntu.edu.tw/handle/123456789/473573We present a patient with ovarian atypical proliferative serous tumor and low-grade serous carcinoma, related to KRAS mutation. Bilateral fallopian tubes had papillary tubal hyperplasia, providing additional evidence that it is the putative precursor of low-grade serous tumors. Mutation analysis of papillary tubal hyperplasia has not been done in previous literature. ? 2013 Mosby, Inc. All rights reserved.[SDGs]SDG3antineoplastic agent; carcinoembryonic antigen; K ras protein; tumor antigen; abdominal distension; adult; anorexia; article; ascites; bladder; bloating; cancer chemotherapy; case report; computer assisted tomography; cytoreductive surgery; disease association; echography; endoscopy; female; frozen section; gene mutation; genetic analysis; human; human cell; human tissue; hypertension; hysterectomy; omentectomy; ovary atypical proliferative serous tumor; ovary carcinoma; ovary low grade serous carcinoma; papillary tubal hyperplasia; peritoneum; physical examination; priority journal; salpingooophorectomy; tumor cell; tumor volume; uterine tube diseasejournal article10.1016/j.ajog.2013.05.0442-s2.0-84880908725